{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:13:19Z","timestamp":1791231199377,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Internal Grant Agency of the Czech Ministry of Health","award":["NS 13890-4"],"award-info":[{"award-number":["NS 13890-4"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jsbmb.2012.08.009","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T12:46:31Z","timestamp":1345812391000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia"],"prefix":"10.1016","volume":"133","author":[{"given":"Marie","family":"Bicikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ripova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hampl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2012.08.009_bib0005","first-page":"1","article-title":"Neurosteroids: of the nervous system by the nervous system, for the nervous system. Recent Prog","volume":"52","author":"Baulieu","year":"1997","journal-title":"Hormone Research"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevNeurobiol.v15.i34.20","article-title":"Pharmacology of endogenous neuroactive steroids","volume":"15","author":"Reddy","year":"2003","journal-title":"Critical Reviews in Neurobiology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2004.11.001","article-title":"Steroids neuroactive steroids and neurosteroids in psychopathology","volume":"29","author":"Dubrovsky","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(24)39294-8","article-title":"Geometry and charge determine pharmacological effects of steroids on N-methyl-d-aspartate receptor-induced Ca(2+) accumulation and cell death","volume":"293","author":"Weaver","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/frne.1999.0188","article-title":"Neurosteroids: biosynthesis and function of these novel neuromodulators","volume":"21","author":"Compagnone","year":"2000","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0030","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.2174\/138161208786848838","article-title":"Neuroactive steroids as endogenous modulators of anxiety","volume":"14","author":"Eser","year":"2008","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0035","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.neuroscience.2005.07.007","article-title":"Neuroactive steroids as modulators of depression and anxiety","volume":"138","author":"Eser","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroscience.2011.03.025","article-title":"Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs","volume":"191","author":"Sch\u00fcle","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1528-1167.2005.00705.x","article-title":"Anticonvulsant activity of androsterone and etiocholanolone","volume":"46","author":"Kaminski","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/jpet.110.169854","article-title":"The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors J","volume":"334","author":"Reddy","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(99)01381-5","article-title":"Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites","volume":"830","author":"Park-Chung","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0026-895X(25)08656-0","article-title":"3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons","volume":"46","author":"Park-Chung","year":"1994","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/mol.52.6.1113","article-title":"Distinct sites for inverse modulation of N-methyl-d-aspartate receptors by sulfated steroids","volume":"52","author":"Park-Chung","year":"1997","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0075","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1523\/JNEUROSCI.0281-09.2009","article-title":"Pregnanolone sulfate promotes desensitization of activated NMDA receptors","volume":"29","author":"Kussius","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0361-9230(02)00885-7","article-title":"Modulation of glutamate receptor expression by gonadal steroid hormones in the rat striatum","volume":"59","author":"D'Souza","year":"2003","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2010.04.003","article-title":"Sigma receptors: potential targets for a new class of antidepressant drug","volume":"127","author":"Fishback","year":"2010","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","article-title":"The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus","volume":"578","author":"Martina","year":"2007","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggests a link between endocrine nervous, and immune systems","volume":"240","author":"Su","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0105","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","article-title":"Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"S\u00e1nchez","year":"2010","journal-title":"CNS Neuroscience and Therapeutics"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2009.00118.x","article-title":"Pregnenolone dehydroepiandrosterone, and schizophrenia: alterations and clinical trials","volume":"16","author":"Ritsner","year":"2010","journal-title":"CNS Neuroscience and Therapeutics"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10571-006-9086-0","article-title":"The relevance of neuroactive steroids in schizophrenia depression, and anxiety disorders","volume":"27","author":"MacKenzie","year":"2007","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/HMBCI.2010.083","article-title":"Altered levels of circulating GABAergic 5 alpha\/beta-reduced pregnane and androstane steroids in schizophrenic men","volume":"6","author":"Bicikova","year":"2011","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0125","first-page":"141","article-title":"Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics","volume":"32","author":"Bicikova","year":"2011","journal-title":"Neuroendocrinology Letters"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jsbmb.2009.10.012","article-title":"Steroid metabolome in plasma from the umbilical artery umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor","volume":"121","author":"Hill","year":"2010","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.0030363","article-title":"Metabolic profiling of patients with schizophrenia","volume":"3","author":"Kaddurah-Daouk","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.0030327","article-title":"Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia","volume":"3","author":"Holmes","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2003.08.011","article-title":"Evidence of basal pituitary-adrenal overactivity in first episode drug naive patients with schizophrenia","volume":"29","author":"Ryan","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0150","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0155","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-4159.2008.05627.x","article-title":"Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum","volume":"107","author":"Whittaker","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.schres.2006.11.020","article-title":"Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder","volume":"90","author":"Gallagher","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.euroneuro.2005.07.007","article-title":"Alterations in DHEA metabolism in schizophrenia: two-month case-control study","volume":"16","author":"Ritsner","year":"2006","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0170","first-page":"141","article-title":"Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology","volume":"l6","author":"Strous","year":"2005","journal-title":"Essential Psychopharmacology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JCP.0b013e31820fcea3","article-title":"Metabolic effects of olanzapine in patients with newly diagnosed psychosis","volume":"31","author":"Fernandez-Egea","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","article-title":"Prolactin concentrations in newly diagnosed antipsychotic-na\u00efve patients with nonaffective psychosis","volume":"134","author":"Garcia-Rizo","year":"2012","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0306-4530(00)00034-2","article-title":"Estradiol levels in psychotic disorders","volume":"26","author":"Huber","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psyneuen.2004.05.010","article-title":"Sex hormones in psychotic men","volume":"30","author":"Huber","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2012.08.009_bib0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2004.06.013","article-title":"Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics","volume":"73","author":"Bergemann","year":"2005","journal-title":"Schizophrenia Research"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076012001525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076012001525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:40:48Z","timestamp":1760744448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076012001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"alternative-id":["S0960076012001525"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2012.08.009","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2012.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}